Browsing Tag
Foresight Diagnostics
2 posts
Natera boosts ctDNA and lymphoma detection capabilities through Foresight Diagnostics acquisition
Find out how Natera’s acquisition of Foresight Diagnostics could redefine ultra-sensitive cancer detection and reshape the future of MRD testing.
Foresight Diagnostics strikes licensing deal with Roche for PhasED-Seq in non-Hodgkin’s lymphoma
Foresight Diagnostics licenses PhasED-Seq to Roche for Non-Hodgkin’s Lymphoma diagnostics, settling litigation and boosting precision oncology prospects.